(2R,3R,4S,5R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol, 95.0%, 100g

(4R)-4-[(1S)-1-fluoroethyl]-3-(2-{[(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]amino}pyrimidin-4-yl)-1,3-oxazolidin-2-one, 1mg

(S)-Ethyl 2-(4-benzylmorpholin-3-yl)acetate, 95.0%, 1g

Methyl 5-amino-4-cyano-3-methylthiophene-2-carboxylate, 95.0%, 25g

Tetrabutylammonium Difluorotriphenylsilicate>97.0%(T)25g

(2-OXO-1,3-DIOXOLAN-4-YL)METHYL METHACRYLATE, 95.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid, 95.0%, 100mg

(6-Bromo-2-fluoro-3-iodophenyl)methanol, 97%, 5g

tert-Butyl 2-aminoacetate, 95.0%, 100g

Viales de muestra con kit de viales ND9 de rosca corta, certificado HPLC, vidrio transparente, con espacio para rotulación, 1 juego

(1R,2S)-2-(4-methoxyphenyl)cyclopropan-1-amine hydrochloride, 250mg

Aminoterephthalic acid, 95.0%, 10g

4-Methoxybenzyl 2,2,2-Trichloroacetimidate>96.0%(GC)25g